An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

The Elizabeth Glaser Pediatric AIDS Foundation said the latest cuts will deprive 350,000 people of HIV treatment.

The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

Dolutegravir is one of the most effective and safest HIV medicines and is used by millions of adults and adolescents living ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

“HIV treatment is crumbling ... s transpired over the last three or four days just takes it to a whole new level of cruelty and inhumanity and, frankly, a whole new level of stupidity ...

In the fight against HIV, one of the most vulnerable populations is often overlooked - newborn babiesIt is estimated that 120,000 new HIV infections occur in children aged 14 years and younger every ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

However, community-based services supporting recruitment and adherence have not resumed and are seeking alternative funding sources. IMPACVIH: This community-based organization (CBO) was negotiating ...